Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Loading...
We’re glad to see you’re enjoying PACE-CME…but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.